Quarterly report pursuant to Section 13 or 15(d)

Document and Entity Information

v3.4.0.3
Document and Entity Information - shares
3 Months Ended
Mar. 31, 2016
May. 11, 2016
Document and Entity Information [Abstract]    
Entity Registrant Name Adaptimmune Therapeutics PLC  
Entity Central Index Key 0001621227  
Document Type 10-Q  
Document Period End Date Mar. 31, 2016  
Amendment Flag false  
Current Fiscal Year End Date --12-31  
Entity Current Reporting Status Yes  
Entity Filer Category Non-accelerated Filer  
Entity Common Stock, Shares Outstanding   424,711,900
Document Fiscal Year Focus 2016  
Document Fiscal Period Focus Q1